Please login to the form below

Not currently logged in
Email:
Password:

drug development

This page shows the latest drug development news and features for those working in and with pharma, biotech and healthcare.

AbbVie calls time on Reata alliance, claims $330m payback

AbbVie calls time on Reata alliance, claims $330m payback

candidates outside certain Asian markets where the drug is licensed to Kyowa Hakko Kirin. ... methyl. “Regaining these rights will increase Reata’s strategic flexibility and control regarding the development and commercialisation of our lead drug

Latest news

More from news
Approximately 21 fully matching, plus 832 partially matching documents found.

Latest Intelligence

  • The Golden Goose The Golden Goose

    Why it’s so hard for the US to curb runaway drug prices. ... A recent white paper puts it more tactfully: “The pharmaceutical industry is a truly international industry with drug research and development, manufacturing and distribution occurring

  • Cooking up a co-creation feast – beyond vanilla Cooking up a co-creation feast – beyond vanilla

    Another challenge for us as agencies is to nudge our clients to involve the end user earlier and earlier in the drug development process. ... Often, we co-design material to support the use of a drug during its clinical development.

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    it into a drug candidate with commercial potential and taking it all the way to market with strong financing and sound management. ... The new fund will be used to back projects across the full healthcare continuum, including researchers who have a great

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    Harmonisation has been addressed in this case by the development of a ‘complementary’ diagnostic by DAKO, which can be used to indicate PD-1/PD-L1 therapy independent of specific drug,” ... The potential downside, Magid Diefenbach said, is that

  • Spotlight on Patient Engagement Spotlight on Patient Engagement

    From clinical trials to the regulatory process and beyond, patient engagement should be a critical part of every drug’s development and its subsequent post-approval lifecycle.

More from intelligence
Approximately 6 fully matching, plus 119 partially matching documents found.

Latest appointments

  • New hires at Bayer, Eisai and Accord Healthcare New hires at Bayer, Eisai and Accord Healthcare

    Chaturvedi will be responsible for developing, implementing and monitoring global policies and procedures, to assure the worldwide compliance with good clinical practices and the laws and regulations governing drug development. ... Grosso will be

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    I am delighted to welcome Frank to the team at this exciting stage in the company’s development. ... The combination of his strong experience in regulatory affairs, not only with the FDA but on a broad international basis with a proven track record and

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Dr. Rickard’s extensive expertise in respiratory drug development, combined with her strong leadership skills will be a tremendous asset as we prepare for the pivotal phase 3 clinical development programme ... Prior to joining Verona Pharma, she was a

  • New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

    Mader brings a track record of drug discovery experience to the biotech, most recently working for Eli Lilly, where she contributed to the development of multiple clinical candidates. ... Meanwhile, Mahesh Padval also joins Relay as senior vice president

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries. ... Atkins said: “Britten joins our Senior Management team at a pivotal time in the Company’s development.

More from appointments
Approximately 1 fully matching, plus 171 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 43 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics